Skip to content

Long-term Outcomes of Colonic Stent as a Bridge to Surgery for Malignant Large-bowel Obstruction

Long-term Outcomes of Colonic Stent as a Bridge to Surgery for Malignant Large-bowel Obstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04111042
Enrollment
117
Registered
2019-10-01
Start date
2016-04-30
Completion date
2019-08-31
Last updated
2019-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stent Occlusion, Long-term Oncologic Results

Keywords

Malignant colonic obstruction, self-expandable metallic stent

Brief summary

Study of long-term outcomes of colonic stent as a bridge to surgery for malignant large-bowel obstruction.

Detailed description

Prospective observational with retrospective analisis study of patients with left-sided malignant colonic obstruction undergoing stenting between April 2006 and April 2018 in Parc Tauli University Hospital. We assessed all patients with intent-to-treat and per protocol analyses in postoperative and long-term follow-up variables.

Interventions

DEVICEstenting

stenting procedure in patients diagnosed malignant large bowel occlusion

Sponsors

Xavier Serra-Aracil
CollaboratorUNKNOWN
Anna Pallisera-Lloveras
CollaboratorUNKNOWN
Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged over 18 years diagnosed with complete malignant colonic obstruction confirmed by CT. * Elective surgery. * Location in transverse, left or sigmoid colon. * Patients who signed the informed consent documentation and agreed to undergo the procedure.

Exclusion criteria

* Benign pathology and palliative treatment. * Unresectable lesion (intraoperative), severe ischemia or cecal perforation, fecal or advanced purulent peritonitis, emergency surgery. * Previous chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
long-term outcomes2 yearssurvival rates

Secondary

MeasureTime frameDescription
anastomotic leak30 dayssurgery

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026